Sharing Our Perspective - Archive

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights Blog is where we share our perspective and challenge preconceptions to clear a new path forward.




  • Lots of Changes in CMS’ Latest WCMSA Reference Guide

    Nov 07, 2019
    Tag Icon
    Side Effects, Medicare Insights, medicareinsights blog, CMS, WCMSA
    On October 10, 2019, the Centers for Medicare and Medicaid Services (CMS) published its latest Workers’ Compensation Medicare Set-Aside Arrangement (WCMSA) Reference Guide.


  • How comorbid respiratory diseases & smoking impact injured claimant outcomes: Part four

    Oct 31, 2019
    Tag Icon
    Clinical Intervention, Comorbidities, comorbidity
    Respiratory health is an important but often overlooked component of a person’s overall health and well-being. Respiratory issues not only can worsen an injured person’s prognosis, but can increase the risk of adverse health effects in some working environments.


  • Comorbid High Blood Pressure in the Injured Individual: Part three

    Oct 23, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Clinical, Chronic Pain, Comorbidities
    Part three of our series discusses how injuries can often lead to comorbidity and complications that can lengthen the duration of treatment, delay return to work and increase costs.


  • Comorbid Mental Health Disorders in Workers’ Compensation & Auto No-fault: Part two

    Oct 17, 2019
    Tag Icon
    Auto No-Fault, Workers' Compensation, mental health, comorbidity, Comorbidities
    Comorbid mental health issues can lengthen return-to-work times and increase costs in workers' comp and auto no-fault. Learn about the impact of mental health comorbidity and what steps to take to mitigate its effect.


  • Comorbidity and Injured Individuals: Part one

    Oct 09, 2019
    Tag Icon
    MSA, Medicare Set-Aside, Medicare Insights, Comorbidities, clinical info, Clinical
    Comorbid conditions in workers’ compensation and auto no-fault can create a trifecta of negative outcomes and aggravate an already difficult situation for an injured individual. In Part one of our series on comorbidities, we will define what they are and describe the three ways comorbidities can make a bad situation worse.


  • Generic Lyrica® price drop and other updates ― significant MSA savings

    Sep 09, 2019
    Tag Icon
    Medicare Insights, Medicare Set-Aside, WCMSA, Lyrica, MSA
    The Workers’ Compensation Medicare Set Aside (WCMSA) portal has been updated to reflect new lower cost generic formulations of Lyrica®, as well as additional medication price decreases.


  • AWP price decrease for tizanidine tablets hits the WCMSA portal

    Aug 07, 2019
    Tag Icon
    Medicare Insights, medicareinsights blog, AWP
    A new lower price for tizanidine HCL 4 mg tablets is now reflected in the Workers’ Compensation Medicare Set Aside (WCMSA) portal pricing. It was updated August 2, 2019 due to a new lower RED BOOK® Average Wholesale Price (AWP).


  • First generics for Lyrica® arrive to market ― significant savings expected

    Aug 06, 2019
    Tag Icon
    Generics, Pain Management, Pharmacy, Medicare Insights, medicareinsights blog, Lyrica
    The Workers’ Compensation Medicare Set Aside (WCMSA) portal has been updated to reflect some of the generic formulations of Lyrica® (updates listed below). We expect to see significant savings with the addition of these generics to the marketplace.


  • FDA approves first alternative medications to Lyrica (pregabalin)

    Jul 22, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Medicare Insights, Settlement Solutions, Pain Management, Lyrica, Clinical
    Much anticipated alternative medications for Lyrica® (pregabalin) were approved by the U.S. Food and Drug Administration (FDA) on July 19, 2019. This approval follows a six-month delay announced last year. Pregabalin is an anticonvulsant with FDA approval to treat neuropathic (nerve) pain associated with diabetes, postherpetic neuralgia (shingles), fibromyalgia and neuropathic pain associated with spinal cord injury. In addition, it is approved as adjunct therapy for the treatment of partial onset seizures.


  • Our Industry Trends Report is now available

    May 06, 2019
    Tag Icon
    Analytics, Ancillary, Drug Formulary, Medicare Set-Aside, Opioids, Optum Workers Comp Auto No Fault, Predictive Analytics, Settlement Solutions, Workers' Compensation
    A 2018 REVIEW OF THE PREVAILING INDUSTRY INFLUENCES IMPACTING CLAIM OUTCOMES


Stay informed by receiving latest updates

Do you have a question about a blog post?